title: Clinical pancreatic transplantation using the prolamine duct occlusion technique--the Munich experience.
authors.forename: W
authors.initials: W
authors.lastname: Land
authors.forename: R
authors.initials: R
authors.lastname: Landgraf
authors.forename: W D
authors.initials: WD
authors.lastname: Illner
authors.forename: D
authors.initials: D
authors.lastname: Abendroth
authors.forename: A
authors.initials: A
authors.lastname: Kampik
authors.forename: U
authors.initials: U
authors.lastname: Jensen
authors.forename: F P
authors.initials: FP
authors.lastname: Lenhart
authors.forename: D
authors.initials: D
authors.lastname: Burg
authors.forename: G
authors.initials: G
authors.lastname: Hillebrand
authors.forename: L A
authors.initials: LA
authors.lastname: Castro
mesh_terms: D003922:Diabetes Mellitus, Type 1 / Q000628:therapy; D003973:Diatrizoate; D004338:Drug Combinations; D005227:Fatty Acids; D005500:Follow-Up Studies; D006801:Humans; D007165:Immunosuppression Therapy; D016035:Pancreas Transplantation; D010183:Pancreatic Ducts / Q000187:drug effects*; D011182:Postoperative Care; D011409:Propylene Glycols; D011506:Proteins / Q000627:therapeutic use*; D009927:Tissue and Organ Procurement; D015028:Zein
chemical_list: D004338:Drug Combinations; D005227:Fatty Acids; D011409:Propylene Glycols; D011506:Proteins; D003973:Diatrizoate; D015028:Zein; C020481:alcoholic prolamine solution